Endocrine disruptors and testicular function
(2018) In Metabolism: Clinical and Experimental 86. p.79-90- Abstract
Despite concerns of the scientific community regarding the adverse effects of human exposure to exogenous man-made chemical substances or mixtures that interfere with normal hormonal balance, the so called “endocrine disruptors (EDs)”, their production has been increased during the last few decades. EDs' extensive use has been implicated in the increasing incidence of male reproductive disorders including poor semen quality, testicular malignancies and congenital developmental defects such as hypospadias and cryptorchidism. Several animal studies have demonstrated that exposure to EDs during fetal, neonatal and adult life has deleterious consequences on male reproductive system; however, the evidence on humans remains ambiguous. The... (More)
Despite concerns of the scientific community regarding the adverse effects of human exposure to exogenous man-made chemical substances or mixtures that interfere with normal hormonal balance, the so called “endocrine disruptors (EDs)”, their production has been increased during the last few decades. EDs' extensive use has been implicated in the increasing incidence of male reproductive disorders including poor semen quality, testicular malignancies and congenital developmental defects such as hypospadias and cryptorchidism. Several animal studies have demonstrated that exposure to EDs during fetal, neonatal and adult life has deleterious consequences on male reproductive system; however, the evidence on humans remains ambiguous. The complexity of their mode of action, the differential effect according to the developmental stage that exposure occurs, the latency from exposure and the influence of the genetic background in the manifestation of their toxic effects are all responsible factors for the contradictory outcomes. Furthermore, the heterogeneity in the published human studies has hampered agreement in the field. Interventional studies to establish causality would be desirable, but unfortunately the nature of the field excludes this possibility. Therefore, future studies based on standardized guidelines are necessary, in order to estimate human health risks and implement policies to limit public exposure.
(Less)
- author
- Lymperi, Stefania and Giwercman, Aleksander LU
- organization
- publishing date
- 2018-01-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Anogenital distance, Cryptorchidism, Endocrine disruptors, Hypospadias, Male infertility, Testicular cancer, Testicular dysgenesis syndrome
- in
- Metabolism: Clinical and Experimental
- volume
- 86
- pages
- 79 - 90
- publisher
- Elsevier
- external identifiers
-
- scopus:85046377508
- pmid:29605435
- ISSN
- 0026-0495
- DOI
- 10.1016/j.metabol.2018.03.022
- language
- English
- LU publication?
- yes
- id
- fa932a8a-f00d-47f9-9cf7-18d9c8cb0642
- date added to LUP
- 2018-05-17 14:30:07
- date last changed
- 2024-06-10 12:35:50
@article{fa932a8a-f00d-47f9-9cf7-18d9c8cb0642,
abstract = {{<p>Despite concerns of the scientific community regarding the adverse effects of human exposure to exogenous man-made chemical substances or mixtures that interfere with normal hormonal balance, the so called “endocrine disruptors (EDs)”, their production has been increased during the last few decades. EDs' extensive use has been implicated in the increasing incidence of male reproductive disorders including poor semen quality, testicular malignancies and congenital developmental defects such as hypospadias and cryptorchidism. Several animal studies have demonstrated that exposure to EDs during fetal, neonatal and adult life has deleterious consequences on male reproductive system; however, the evidence on humans remains ambiguous. The complexity of their mode of action, the differential effect according to the developmental stage that exposure occurs, the latency from exposure and the influence of the genetic background in the manifestation of their toxic effects are all responsible factors for the contradictory outcomes. Furthermore, the heterogeneity in the published human studies has hampered agreement in the field. Interventional studies to establish causality would be desirable, but unfortunately the nature of the field excludes this possibility. Therefore, future studies based on standardized guidelines are necessary, in order to estimate human health risks and implement policies to limit public exposure.</p>}},
author = {{Lymperi, Stefania and Giwercman, Aleksander}},
issn = {{0026-0495}},
keywords = {{Anogenital distance; Cryptorchidism; Endocrine disruptors; Hypospadias; Male infertility; Testicular cancer; Testicular dysgenesis syndrome}},
language = {{eng}},
month = {{01}},
pages = {{79--90}},
publisher = {{Elsevier}},
series = {{Metabolism: Clinical and Experimental}},
title = {{Endocrine disruptors and testicular function}},
url = {{http://dx.doi.org/10.1016/j.metabol.2018.03.022}},
doi = {{10.1016/j.metabol.2018.03.022}},
volume = {{86}},
year = {{2018}},
}